Related Experiment Video
Updated: Jul 9, 2026

Whole Body Vibration Methods with Survivors of Polio
Published on: October 17, 2018
[Paralytic poliomyelitis in Russian Federation in 1998-2005]
Abstract:
From 1998 through 2005 3,294 cases of acute flaccid paralysis (AFP) including 93 cases with clinical picture of poliomyelitis were registered in Russian Federation. From the latter cases 91 were classified as vaccine-associated paralytic poliomyelitis (VAPP): 66 were VAPP cases in oral poliomyelitis vaccine (OPV) recipients and 25--VAPP cases in contacts. VAPP rate was 1 case per 1.6 million of distributed OPV doses, 1 case per 2.2 million doses for OPV recipients, and 1 case per 186,000 doses for recipients of 1st OPV dose in children aged < 1 year. Majority of VAPP cases in recipients occurred after 1st dose (89.4%) and in contacts--in non-vaccinated children (76%). Mean interval between OPV administration and onset of VAPP in recipients was 21 days. Children aged < 1 year were predominant among VAPP cases (92.4% among recipient VAPP cases, and 80% among contact VAPP cases). Majority of the patients had unfavorable health status including defects of immunity. Most of poliovirus strains isolated from VAPP cases belonged to type 3 (52.9%) whereas to type 2 and 1--29.8% and 17.4% of strains respectively. All VAPP cases were associated with vaccine-derived polioviruses. A highly diverged poliovirus type 1 (2.65% of nucleotide substitutions in VP1 region) was isolated from patient with contact VAPP. Formation of poliovirus-neutralizing serum antibodies in children with VAPP including persons with immunodeficiency reflects the ability of the organism to produce specific antiviral immune response.
Insights
Vaccine-associated paralytic poliomyelitis (VAPP) occurred at low rates in the Russian Federation, primarily affecting infants and those with immune deficiencies. Most cases involved vaccine-derived polioviruses, predominantly type 3.
Area of Science:
- Virology
- Epidemiology
- Immunology
Context:
- Acute flaccid paralysis (AFP) surveillance in the Russian Federation from 1998-2005 registered 3,294 cases.
- Of these, 93 presented with poliomyelitis symptoms, leading to 91 classified as vaccine-associated paralytic poliomyelitis (VAPP).
Purpose:
- To analyze the incidence, characteristics, and etiological agents of VAPP cases in the Russian Federation.
- To assess the risk factors and demographic distribution of VAPP.
Summary:
- VAPP rates were low: 1 per 1.6 million oral poliovirus vaccine (OPV) doses distributed. Infants under one year and individuals with immune defects were most affected.
- Most VAPP cases (66 recipients, 25 contacts) were linked to vaccine-derived polioviruses, particularly type 3. A divergent type 1 poliovirus was identified in a contact VAPP case.
- The mean interval between OPV administration and VAPP onset was 21 days, with most recipient cases occurring after the first OPV dose.
Impact:
- Findings highlight the risks associated with OPV, especially in vulnerable populations, and the importance of continued surveillance for VAPP.
- The study demonstrates the potential for vaccine-derived polioviruses to cause VAPP and underscores the immune system's capacity to generate neutralizing antibodies even in immunodeficient individuals.
Related Concept Videos
Poliomyelitis
Arboviral Encephalitis
Rabies
Rocky Mountain Spotted Fever
Diphtheria
Botulism

